Jiaxian Yu

518 total citations · 2 hit papers
8 papers, 366 citations indexed

About

Jiaxian Yu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jiaxian Yu has authored 8 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jiaxian Yu's work include Cancer-related molecular mechanisms research (3 papers), Zebrafish Biomedical Research Applications (2 papers) and Cancer, Lipids, and Metabolism (2 papers). Jiaxian Yu is often cited by papers focused on Cancer-related molecular mechanisms research (3 papers), Zebrafish Biomedical Research Applications (2 papers) and Cancer, Lipids, and Metabolism (2 papers). Jiaxian Yu collaborates with scholars based in China and Canada. Jiaxian Yu's co-authors include Wenchang Yang, Yuping Yin, Kaixiong Tao, Ruidong Li, Yongzhou Huang, Liang Shi, Peng Zhang, Yaxin Wang, Chengguo Li and Chenggang Zhang and has published in prestigious journals such as Scientific Reports, Free Radical Biology and Medicine and Frontiers in Pharmacology.

In The Last Decade

Jiaxian Yu

8 papers receiving 365 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Maresin1 Protect Against Ferroptosis-Induced Liver Injury Through ROS Inhibition and Nrf2/HO-1/GPX4 Activation

2022 145 citations Wenchang Yang, Yaxin Wang et al. Frontiers in Pharmacology profile →
4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer

2023 124 citations Wenchang Yang, Yaxin Wang et al. Biomedicine & Pharmacotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiaxian Yu China	6	214	132	118	59	50	8	366
Yongzhou Huang China	6	254 1.2×	141 1.1×	120 1.0×	85 1.4×	67 1.3×	16	423
Wangjia Cao China	5	278 1.3×	248 1.9×	193 1.6×	41 0.7×	35 0.7×	7	457
Zhaofeng Pan China	9	255 1.2×	83 0.6×	124 1.1×	27 0.5×	34 0.7×	16	402
Shuo Miao China	12	232 1.1×	49 0.4×	122 1.0×	66 1.1×	61 1.2×	24	410
Jiacong Xiao China	9	242 1.1×	83 0.6×	122 1.0×	24 0.4×	28 0.6×	19	389
Xiaotian Xu China	12	209 1.0×	103 0.8×	136 1.2×	53 0.9×	53 1.1×	27	383
Yangmin Qiu China	5	269 1.3×	242 1.8×	204 1.7×	69 1.2×	94 1.9×	5	492
Jintong Yang China	14	253 1.2×	142 1.1×	68 0.6×	122 2.1×	33 0.7×	18	437

Countries citing papers authored by Jiaxian Yu

Since Specialization

Citations

This map shows the geographic impact of Jiaxian Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaxian Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaxian Yu more than expected).

Fields of papers citing papers by Jiaxian Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiaxian Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaxian Yu. The network helps show where Jiaxian Yu may publish in the future.

Co-authorship network of co-authors of Jiaxian Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiaxian Yu. A scholar is included among the top collaborators of Jiaxian Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiaxian Yu. Jiaxian Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Yu, Jiaxian, et al.. (2023). Protective effect of N-(E)-p-coumaroyltyrosine on LPS-induced acute inflammatory injury and signaling pathway analysis. Fish & Shellfish Immunology. 144. 109242–109242. 6 indexed citations

2.

Zhang, Chenggang, Peng Zhang, Jiaxian Yu, et al.. (2023). Laparoscopic versus open gastrectomy for locally advanced gastric cancer after neoadjuvant chemotherapy: a comprehensive contrastive analysis with propensity score matching. World Journal of Surgical Oncology. 21(1). 350–350. 1 indexed citations

3.

Yang, Wenchang, Yaxin Wang, Yongzhou Huang, et al.. (2023). 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer. Biomedicine & Pharmacotherapy. 159. 114301–114301. 124 indexed citations breakdown →

4.

Huang, Yongzhou, Wenchang Yang, Lei Yang, et al.. (2023). Nrf2 inhibition increases sensitivity to chemotherapy of colorectal cancer by promoting ferroptosis and pyroptosis. Scientific Reports. 13(1). 14359–14359. 42 indexed citations

5.

Yu, Jiaxian, et al.. (2022). Abrusamide H Impairs the Secretion of the Cytokines in RAW264.7 Cells and the Inflammatory Infiltration in Tail Transection‐Induced Zebrafish. Chemistry & Biodiversity. 19(11). e202200474–e202200474. 7 indexed citations

6.

Yang, Wenchang, Yaxin Wang, Peng Zhang, et al.. (2022). Immune-responsive gene 1 protects against liver injury caused by concanavalin A via the activation Nrf2/HO-1 pathway and inhibition of ROS activation pathways. Free Radical Biology and Medicine. 182. 108–118. 37 indexed citations

7.

Yang, Wenchang, Yaxin Wang, Chenggang Zhang, et al.. (2022). Maresin1 Protect Against Ferroptosis-Induced Liver Injury Through ROS Inhibition and Nrf2/HO-1/GPX4 Activation. Frontiers in Pharmacology. 13. 865689–865689. 145 indexed citations breakdown →

8.

Hu, Ke, et al.. (2017). [Alpinetin promotes the binding of PPAR and methyltransferase].. PubMed. 33(12). 1610–1614. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yongzhou Huang Breakdown of academic impact, for papers by Wangjia Cao Breakdown of academic impact, for papers by Zhaofeng Pan Breakdown of academic impact, for papers by Shuo Miao Breakdown of academic impact, for papers by Jiacong Xiao Breakdown of academic impact, for papers by Xiaotian Xu Breakdown of academic impact, for papers by Yangmin Qiu Breakdown of academic impact, for papers by Jintong Yang